Atlantic American Corporation Common Stock (AAME)
TurnaroundFairStock Score: 74/100 — STEADY
Key Financials
| Current Price | $1.24 |
| Market Cap | $25M |
| P/E Ratio | 5.39 |
| ROE | 4.75% |
| Dividend Yield | 0.84% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look for a durable business bought at a sensible price, and Atlantic American is a small insurer—153 employees—selling life and health plus property and casualty products through American Southern and Bankers Fidelity. Its niche commercial auto and surety lines may create some customer stickiness, but insurance is a commodity business and scale matters; I see no wide moat. The filed record is uneven: FY2022 net income was $1.5M, FY2023 was a loss of $171,000, and FY2024 was a loss of $4.3M. FairStock labels it TURNAROUND because of the latest-year loss after earlier profits, and that fits. Recent quarters are better: fiscal Q1 2025 net income was $802,000, fiscal Q2 2025 was $3.3M, and fiscal Q3 2025 was $577,000 on revenue of $53.8M, up from $44.5M in fiscal Q3 2024. Still, the fiscal Q3 2025 net margin was only 1.07%. At the 2026-10-13 close, FairStock calculates a P/E of 4.91, P/B of 0.21, ROE of 4.75%, ROCE of 1.49%, and D/E of 0.39. The price looks statistically cheap, but low returns, inconsistent earnings, and a $23.0M market cap explain why. Key underwriting measures—combined ratio—and bank-style CET1 and NIM are not in the data, so I cannot fully judge credit or reserve risk. I would want evidence that 2025 profitability is repeatable before trusting the discount.
In plain English: Atlantic American sells life, health, and property-and-casualty insurance, mainly to niche customers like municipal fleets. The business has been uneven: recent quarters made money, but the full fiscal 2024 year was a loss and returns on shareholder money are low. The stock price is very low compared with the company’s reported earnings and accounting value, but that cheapness may reflect real risks in a small, inconsistent insurer.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · fiscal Q1 2025 10-Q (period ended 2025-03-31) · fiscal Q3 2024 10-Q (period ended 2024-09-30) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31) · FY2022 10-K (period ended 2022-12-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer